Degree of Weight Loss Affects Tirzepatide-Linked Cardiometabolic Risk Improvement
Physician's Weekly
JULY 1, 2025
“Understanding whether there are specific thresholds of weight reduction associated with minimum or maximum cardiometabolic benefits may assist clinicians in tailoring weight reduction goals to individual patients seeking to reduce their cardiometabolic risk,” the authors write. Bruno Linetzky, M.D.,
52 
Let's personalize your content